2.11

0.00% 0.00

After Hours: 2.10 -0.010 -0.47%

Dare Bioscience Inc (DARE)

Overview News Price History Financials Discussions Forecast Stock Split

Dare Bioscience Inc stock is traded at $2.11, with a volume of 73,876. It is up +0.00% in the last 24 hours and up +3.94% over the past month. Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Previous Close:

$2.11

Open:

$2.13

24h Volume:

73,876

Relative Volume:

0.05

Market Cap:

$28.44M

Revenue:

Net Income/Loss:

$-30.16M

P/E Ratio:

-6.2059

EPS:

-0.34

Net Cash Flow:

$-39.49M

1W Performance:

-1.86%

1M Performance:

+3.94%

6M Performance:

-29.67%

1Y Performance:

-37.01%

1-Day Range:

$2.07

$2.1471

1-Week Range:

$2.05

$2.16

52-Week Range:

$1.83

$9.19

Dare Bioscience Inc Stock (DARE) Company Profile

Name

Dare Bioscience Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

858-926-7655

Address

3655 NOBEL DRIVE, SAN DIEGO, CA

Employee

Twitter

@DareBioscience

Next Earnings Date

2024-11-07

Latest SEC Filings

DARE's Discussions on Twitter

Compare DARE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DARE Dare Bioscience Inc	2.11	28.71M	0	-30.16M	-39.49M	-0.34
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Dare Bioscience Inc Stock (DARE) Latest News

Sep 12, 2025

Using Python tools to backtest Daré Bioscience Inc. strategies2025 Price Action Summary & Comprehensive Market Scan Insights - Newser

Sep 12, 2025

Sep 04, 2025

Maxim upgrades Daré Bioscience on extended cash runway, commercial launch - TradingView

Sep 04, 2025

Maxim Group upgrades Dare Bioscience stock to Buy on funding boost - Investing.com Canada

Sep 04, 2025

Dare Bioscience (DARE) Upgraded to Buy by Maxim Group | DARE Sto - GuruFocus

Sep 04, 2025

Dare Bioscience shares rise 4.37% premarket after Maxim upgraded to Buy from Hold. - AInvest

Sep 04, 2025

Dare Bioscience: Maxim Group upgrades Buy from Hold, PT $8. - AInvest

Sep 04, 2025

Maxim Upgrades Dare Bioscience to Buy From Hold, Price Target is $8 - MarketScreener

Sep 04, 2025

Sep 03, 2025

Daré Bioscience Engages Market with New Presentation - TipRanks

Sep 03, 2025

Aug 28, 2025

Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call Transcript - MSN

Aug 28, 2025

Aug 23, 2025

Pattern recognition hints at Daré Bioscience Inc. upsideQuarterly Trade Review & Long-Term Safe Investment Ideas - Newser

Aug 23, 2025

Aug 19, 2025

Brookline Capital Markets Sticks to Their Buy Rating for Daré Bioscience (DARE) - The Globe and Mail

Aug 19, 2025

Dolliver Maintains Buy Rating on Daré Bioscience with $11 Price Target - AInvest

Aug 19, 2025

Aug 18, 2025